Journal Publications
Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.
| Author(s) | Date |
Article Title |
Journal |
|---|---|---|---|
|
Alberto Martini, Anish B. Parikh, John P. Sfakianos, Francesco Montorsi, Matthew D. Galsky, William K. Oh, Che-Kai Tsao |
February 2021 | Predicting toxicity-related docetaxel discontinuation and overall survival in metastatic castration-resistant prostate cancer: a pooled analysis of open phase 3 clinical trial data | Prostate Cancer and Prostatic Diseases |
|
Anish B. Parikh, Alberto Martini, John Sfakianos, Matt D. Galsky, William K. Oh, Che-Kai Tsao |
February 2020 | Predicting toxicity-related docetaxel discontinuation and survival in metastatic castration-resistant prostate cancer (mCRPC) using open phase III trial data | Journal of Clinical Oncology |
|
Junjie Hang, Lixia Wu, Lina Zhu, Khigiang Sun, Ge Wang, Jingjing Pan, Suhua Zheng, Kequn Xu, Jiadi Du, Hua Jiang |
June 2018 | Prediction of Overall Survival for Metastic Pancreatic Cancer: Development and Validation of a Prognostic Nomogram with Data from Open Clinical Trial and Real-World Study | Cancer Medicine |
|
Justin Guinney, Tao Wang, Teemu D. Laajala, Kimberly Kanigel Winner, J. Christopher Bare, Elias Chaibub Neto, Suleiman A. Khan, Gopal Peddinti, Antti Airola, Tapio Pahkkala, Tuomas Mirtti, Thomas Yu, Brian M. Bot, Liji Shen, Kald Abdallah, Thea Norman, Stephen Friend, Gustavo Stolovitzky, Howard Soule, Christopher J. Sweeney, Charles J. Ryan, Howard I. Scher, Oliver Sartor, Yang Xie, Tero Aittokallio, Fang Liz Zhou, James C. Costello |
January 2017 | Prediction of Overall Survival for Patients with Metastatic Castration-Resistant Prostate Cancer: Development of a Prognostic Model Through a Crowdsourced Challenge with Open Clinical Trial Data | The Lancet Oncology |
|
Omar Abdel-Rahman |
July 2018 | Predictors of skeletal-related events among cancer patients with bone metastases treated with zoledronic acid: a secondary analysis of a randomized study | Expert Opinion on Drug Safety |
|
Omar Abdel-Rahman and Osama Ahmed |
January 2019 | Predictors of toxicity-related hospitalization in four randomized studies of 5-fluorouracil-based chemotherapy in metastatic colorectal cancer | International Journal of Colorectal Disease |
|
Liling Huang , Shiyu Jiang & Yuankai Shi |
February 2022 | Prognostic significance of baseline neutrophil–lymphocyte ratio in patients with non-small-cell lung cancer: a pooled analysis of open phase III clinical trial data | futuremedicine |
|
Omar Abdel-Rahman |
March 2019 | Prognostic Value of Baseline ALBI Score Among Patients With Colorectal Liver Metastases: A Pooled Analysis of Two Randomized Trials | Clinical Colorectal Cancer |
|
Wenjuan Mei, Anil Kapoor, Pierre Major, Bobby Shayegan, Damu Tang |
January 2017 | Progress towards accurate prediction of overall survival in men with metastatic castration-resistant prostate cancer | Journal of Xiangya Medicine |
|
Karyn Hede |
August 2017 | Project Data Sphere to Make Cancer Clinical Trial Data Publicly Available | Journal of the National Cancer Institute |
|
Ganessan Kichenadasse MBBS, FRACP, John O. Miners PhD, Arduino A. Mangoni MBBS, PhD, FRACP, Christos S. Karapetis MBBS, FRACP, Ashley M. Hopkins PhD and Michael J. Sorich PhD |
May 2021 | Proton Pump Inhibitors and Survival in Patients With Colorectal Cancer Receiving Fluoropyrimidine-Based Chemotherapy | Journal of the National Comprehensive Cancer Network |
|
Sophia Z.Shalhout, PhD; Jong ChulPark, MD; Kevin S.Emerick,MD; Ryan J.Sullivan, MD; Howard L.Kaufman, MD; David M.MillerMD, PhD |
January 2021 | Real-world assessment of response to anti-PD-1 therapy in advanced cutaneous squamous cell carcinoma | Journal of the American Academy of Dermatology |
|
Justyna Mierzynska, Mekdes Taye, Madeline Pe, Corneel Coens, Francesca Martinelli, Katarzyna Pogoda, Galina Velikova, Vesna Bjelic-Radisic, Fatima Cardoso, Etienne Brain, Michail Ignatiadis, Martine Piccart, Geertjan Van Tienhoven, Robert Mansel, Hans Wildiers, Andrew Bottomley, on behalf of EORTC and EORTC Breast Cancer Group |
December 2019 | Reference values for the EORTC QLQ-C30 in early and metastatic breast cancer | European Journal of Cancer |
|
Theresa Wizemann, Eeshan Khandekar, Jennifer Hinners, Carolyn Shore |
July 2020 | Reflections on Sharing Clinical Trial Data: Challenges and a Way Forward: Proceedings of a Workshop (2020) | National Academies Press |
